How Africa’s Drug Qualification Process is Blocking its Health Independence

*We Can’t Have African Solutions Compiled Elsewhere- African Pharma Makers Story and Photos by John Musenze DURBAN, SOUTH AFRICA – At the just concluded 4th International Conference on Public Health in Africa (CPHIA 2025), the atmosphere in Durban was both defiant and hopeful, health stakeholders including scientists, ministers, and pharmaceutical leaders gathered to unveil what…

Read More

New partnership launched to improve sickle cell disease care in Sub-Saharan Africa

  By Ojoma Akor Novo Nordisk and the American Society of Hematology (ASH) have announced a three-year partnership geared towards supporting the Consortium on Newborn Screening in Africa (CONSA) Community Health Worker (CHW) Initiative. The initiative will be implemented in seven countries across Sub-Saharan Africa: Ghana, Kenya, Liberia, Nigeria, Tanzania, Uganda, and Zambia. The collaboration’s…

Read More

Southern Africa leaders seek collective action for outbreak preparedness , climate resilience

By Health and Science Africa Ministers of Health and senior representatives from ten African Union (AU) Member States in Southern Africa have issued a renewed call for collective action on health financing, climate resilience, and outbreak preparedness. They made the call during the 4th Southern Africa Regional Ministerial Steering Committee (ReSCO) Meeting held in Lilongwe…

Read More

Ebonyi intensifies monitoring of general hospitals for better service delivery

  By Peter Samuel The Ebonyi State Ministry of Health’s monitoring team led by its Permanent Secretary, Dr. Lawrence Ezeogo, has visited five general hospitals outside Abakaliki metropolis: Owutu, Itim-Ukwu, Onueke, Ikwo and Elinwovu, to assess the performance of healthcare personnel. The team toured various wards, theatres and other units and discussed with staff in…

Read More

Lesotho moves towards mass treatment of worm infections

  By Health and Science Africa The Ministry of Health in Lesotho, in collaboration with the World Health Organization (WHO), has initiated steps to re-establish its Mass Drug Administration (MDA) program for Soil-Transmitted Helminths (STH) through the annual administration of albendazole tablets to target both preschool-aged children (1–5 years) and school-aged children (6–15 years). A…

Read More